Skip to main content

Illumina, North American Rheumatoid Arthritis Consortium Pen Genotyping Study Agreement

NEW YORK, Sept. 16 (GenomeWeb News) - Illumina signed an agreement to collaborate on a rheumatoid arthritis genotyping study with the North American Rheumatoid Arthritis Consortium, the company said today.


The study involves the analysis of 3,125 samples using Illumina's Linkage IV SNP panel with its BeadArray platform. NARAC researchers will analyze the data in hopes of identifying genes associated with rheumatoid arthritis, Illumina said. 


The effort is led by Peter Gregersen, director of the RobertS.BoasCenter for Genomics and Human Genetics at the Institute for Medical Research in Manhasset, NY. Gregersen is also the principal investigator of the Multiple Autoimmune Disease Genetics Consortium, an effort by the US National Institutes of Health effort to identify genes linked to autoimmune diseases.


The company declined to disclose financial details of the deal.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.